Sachs Associates would like to say that we have enjoyed hosting you back in-person and virtually and thank those who participated in our Sachs Autumn Life Sciences Week, which incorporated the 10th Annual HealthTech Investment Forum (Sachs_HTIF) and the 23rd Annual Biotech in Europe Forum (Sachs_BEF). A special thank you goes to the excellent line up of sponsors, chairs, panellists and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
The Life Sciences Week has proven to be successful in supporting our community with 586 delegates from 29 countries and over 2200 in-person & online meetings completed.
Publicly available recordings of the sessions and presentations which took place during the event will be added shortly on SachsTV YouTube channel.
We are looking forward to welcoming you again in our future events!
SILVER SPONSORS:
BRONZE SPONSORS:
CONTRIBUTING SPONSORS:
Presenting Companies Included:
Exhibitors Included:
Confirmed Keynote Speakers Included:
Edwin Moses
Independent Director, Achilles Therapeutics plc/ Avantium NV/ LabGenius Ltd.
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Speakers and Chairs Included:
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
Fintan Walton
Founder & CEO, PharmaVentures Ltd.
François Thomas
Operating Partner, Quadrille Capital
Hans Herklots
Managing Director, Second Thought
Marianne Uteng
Managing Director, Novartis Venture Fund
Rainer Strohmenger
Managing Partner, Wellington Partners
Regina Hodits
Managing Director, Angelini Ventures S.p.A.
Stefan Luzi
Partner, Gilde Healthcare Partners B.V.
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Søren Møller
Managing Partner, Novo Holdings A/S
Tahera Kan
VP, Global Business Development Precision Medicine, Johnson & Johnson Innovation | Janssen Business Development
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Alberto Santagostino
SVP, Head of Cell & Gene Technologies Business Unit, Lonza AG
Alex Blyth
CEO, LIfT BioSciences Ltd.
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Andrea Malizia
CEO, IAMA Therapeutics S.r.l.
Antti Vuolanto
CEO, Herantis Pharma Plc
Carolin Barth
Partner & Director, Boston Consulting Group
Catherine Pickering
CEO, iOnctura SA
Christoph Broja
Investment Advisory Professional - Managing Director, EQT Life Sciences
Claudia Ulbrich
CEO, Cardior Pharmaceuticals GmbH
Colette Lipp
Senior Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
Corinne Venot
VP, Global Business Development, BeOne Medicines I GmbH
Dimitrios Weedon-Topalopoulos
Managing Director, OrbiMed Advisors LLC
Eric Halioua
Executive Chairman, Ervimmune
Gerben Moolhuizen
CEO, ISA Pharmaceuticals B.V.
Giovanni Rizzo
Partner Biotech Fund, Indaco Venture Partners SGR S.p.A.
Hermann-Josef Kaiser
VP, Business Development, ARMGO Pharma, Inc.
Hiro Usuda
Scouting & Transaction Lead, Business Development, Astellas Pharma Europe Ltd.
Hubert Birner
Managing Partner, TVM Capital Life Science
Jesús Martin-Garcia
CEO, GeNeuro SA
Klaus Breiner
Managing Partner, Pureos Bioventures
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Laura Lane
VP Lilly Ventures - Head of Europe, Eli Lilly and Company
Luc Boblet
Co-Founder & CEO, Egle Therapeutics SAS
Magne Stoknes
Principal, Novo Holdings A/S
Mankit Law
Senior Director, BD, Search & Evaluation, GSK
Marek Kozlowski
Senior Investment Director, NRW.Bank
Marta Helena Lesko
VP, Head of Immunology & Neurology BD, Merck KGaA, Darmstadt, Germany
Michael Altorfer
CEO, Swiss Biotech Association
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Mike Mulqueen
VP of Business Development,
Mireia Gómez-Angelats
CBO, Topas Therapeutics GmbH
Nicolas Poirier
CEO & CSO, OSE Immunotherapeutics
Pascal Neuville
CEO, Domain Therapeutics SA
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
Paul Bravetti
CEO, Brenus Pharma
Peter Louwagie
SVP Corporate & Business Development, Genmab A/S
Peter C. Kahr
Senior Medical Director, Neurimmune AG
Richard Ward
Executive Director, Oncology Search & Evaluation, GSK
Robbie McLaren
Partner & Global Vice Chair of the Healthcare & Life Sciences Industry Group, Latham & Watkins LLP
Sam Fazeli
Head of Research, Global Industries & Senior Pharmaceuticals Analyst, Bloomberg Intelligence
Seth Goldblum
SVP - Corporate Development, Cullgen Inc.
Simon Molgaard
Co-Founder & CEO, Teitur Trophics ApS
Stefano Portolano
CEO, Azafaros Switzerland AG
Stephan Emmerth
Director, BaseLaunch
Stephane Degove
CEO, Atamyo Therapeutics SAS
Stéphane Boissel
President & CEO, SparingVision
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Thibaut Roulon
Senior Investment Director, Bpifrance
Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi
Yanina Lenz
Senior Director, Scientific Licensing, BD&L & Alliance Management, Pharmaceuticals, Bayer AG